Editorial Type:
Article Category: Research Article
 | 
Online Publication Date: 15 Oct 2012

A Responder Analysis of the Effects of Yoga for Individuals With COPD: Who Benefits and How?

,
,
, and
Page Range: 23 – 36
DOI: 10.17761/ijyt.22.1.84352754221r1774
Save
Download PDF

We previously reported that a twice-weekly, modified Iyengar yoga program was a safe and viable self-management strategy for patients with chronic obstructive pulmonary disease (COPD). 1 Objective: The primary purpose of this exploratory analysis was to classify yoga participants into 1 of 3 responder categories by using minimum clinically important difference (MCID) criteria for each of 3 variables: 6-minute walk distance (6MW), distress related to dyspnea (shortness of breath; DD), and functional performance (FPI). Changes in health-related quality of life (HRQL) and in psychological well-being (anxiety and depression), and participants' self-reported improvements by responder category were also examined. A secondary goal was to identify baseline participant characteristics, including initial randomization assignment that might predict response to treatment. Methods: Participants were randomly assigned to either an initial yoga (IY) or an enhanced wait-list control (WLC) group. Those in the WLC group were offered the yoga program immediately following the IY group's participation. Individuals from both groups who completed at least 18 of 24 yoga classes were categorized as responders, partial responders, or non-responders for each of the 3 outcome variables (6MW, DD, FPI) on the basis of MCID criteria. Baseline characteristics and changes in HRQL and psychological well-being were also analyzed. Results: None of the participants demonstrated MCIDs for all 3 outcomes; however, 6 were classified as responders for 2 out-come variables and 4 were classified as non-responders for all 3 outcome variables. Two-thirds of the female participant group and one-third of the male participant group completed the yoga program. DD responders showed increased anxiety levels, whereas anxiety levels of the DD non-responders remained unchanged. FPI responders reported significant improvements in physical function, whereas partial and non-FPI responders noted declined function. Participants assigned to the IY group demonstrated greater benefit from yoga than did those in the W LC group. Conclusions: Although this modified Iyengar yoga program appears to have benefited some individuals with COPD, further studies are required to assess who the intervention works for and under what conditions.

Donesky-Cuenco D, Nguyen HQ, Paul S, Carrieri-Kohlman V. Yoga therapy decreases dyspnea-related distress and improves functional performance in people with chronic obstructive pulmonary disease: a pilot study. J Altern Complement Med. Mar 200915(3):225-234.

Behera D. Yoga therapy in chronic bronchitis. J Assoc Physicians India. 1998;46(2):207-208.

Tandon MK. Adjunct treatment with yoga in chronic severe airways obstruction. Thorax. 1978;33(4):514-517.

Kulpati DD, Kamath RK, Chauhan MR. The influence of physical conditioning by yogasanas and breathing exercises in patients of chronic obstructive lung disease. J Assoc Physicians India. 1982;30(12):865-868.

Pomidori L, Campigotto F, Amatya TM, Bernardi L, Cogo A. Efficacy and tolerability of yoga breathing in patients with chronic obstructive pulmonary disease: a pilot study. J Cardiopulm Rehabil Prev. Mar-Apr 2009;29(2):133-137.

Fulambarker A, Farooki B, Kheir F, Copur AS, Srinivasan L, Schultz S. Effect of yoga in chronic obstructive pulmonary disease. Am J Ther. 2010;epub ahead of print.

Dionne RA, Bartoshuk L, Mogil J, Witter J. Individual responder analyses for pain: does one pain scale fit all? Trends Pharmacol Sci. Mar 2005;26(3):125-130.

Miaskowski C, Dodd M, West C, et al. The use of a responder analysis to identify differences in patient outcomes following a self-care intervention to improve cancer pain management. Pain. May 2007;129(1-2):55-63.

Lansing RW, Gracely RH, Banzett RB. The multiple dimensions of dyspnea: review and hypotheses. Respir Physiol Neurobiol. May 30 2009;167(1):53-60 Epub 2008 Jul 2025.

Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). http://www.goldcopd.org. Accessed 6/15/2010. http://www.goldcopd.org

Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. Aug 2005;26(2):319-338.

ATS. ATS Statement: Guidelines for the Six-Minute Walk Test. Am J Respir Crit Care Med. 2002;166:111-117.

Burdon JG, Juniper EF, Killian KJ, Hargreave FE, Campbell EJ. The perception of breathlessness in asthma. Am Rev Respir Dis. 1982;126(5):825-828.

Benzo R, Flume PA, Turner D, Tempest M. Effect of pulmonary rehabilitation on quality of life in patients with COPD: the use of SF-36 summary scores as outcomes measures. J Cardiopulm Rehabil. 2000;20(4):231-234.

Mahler DA, Tomlinson D, Olmstead EM, Tosteson AN, O'Connor GT. Changes in dyspnea, health status, and lung function in chronic airway disease. Am J Respir Crit Care Med. 1995;151(1):61-65.

Leidy NK, Knebel AR. In search of parsimony: reliability and validity of the Functional Performance Inventory Short Form. Int Chron Obstruct Pulmon Dis. 2010;25(5):415-423.

Eaton WW, Kessler LG. Rates of symptoms of depression in a national sample. Am J Epidemiol. 1981;114:528-538.

Spielberger C, Gorsuch R, Lushene R, Vagg P, Jacobs G. Manual for the State-Trait Anxiety Inventory (Form Y) (“Self-evaluation questionnaire”) Palo Alto, CA: Consulting Psychologist Press; 1989.

King MT. A point of minimal important difference (MID): a critique of terminology and methods. Pharmacoecon Outcomes Res. 2011;11(2):171-184.

Wise RA, Brown CD. Minimal clinically important differences in the sixminute walk test and the incremental shuttle walking test. Copd. Mar 2005;2(1):125-129.

Carrieri-Kohlman V, Donesky-Cuenco D. Dyspnea: Symptom assessment and management. In: Hodgkin J, Connors G, Celli B, eds. Pulmonary Rehabilitation: Guidelines for Success. 4th ed ed. Philadelphia: Lippincott, Williams & Wilkins; 2008:57-90.

Carmody J, Baer RA. Relationships between mindfulness practice and levels of mindfulness, medical and psychological symptoms and well-being in a mindfulness-based stress reduction program. J Behav Med. Feb 2008;31(1):23-33 Epub 2007 Sep 2025.

Evans S, Tsao J, Sternlieb B, Zeltzer L. Using the biopsychosocial model to understand the health benefits of yoga. J Compl Integrat Med. 2009;6(1): Article 15.

Capouya J. Real men do yoga. Newsweek. 2003;141(24):78-79.

Hesser H, Weise C, Rief W, Andersson G. The effect of waiting: a metaanalysis of wait-list control groups in trials for tinnitus distress. J Psychosom Res. 2011;70(4):378-384.

Carrieri-Kohlman V, Donesky-Cuenco D, Park SK, et al. Additional evidence for the affective dimension of dyspnea in patients with COPD. Res Nurs Health. 2010;33(1):4-19

  • Download PDF